School of Science, Shandong Jiaotong University, Jinan, PR China.
Department of Physics, Jiangxi Agricultural University, Nanchang, PR China.
J Enzyme Inhib Med Chem. 2023 Dec;38(1):84-99. doi: 10.1080/14756366.2022.2135511.
Understanding selectivity-dependent molecular mechanism of inhibitors towards CDK2 over CDK6 is prominent for improving drug design towards the CDK family. Multiple short molecular dynamics (MD) simulations combined with MM-GBSA approach are adopted to investigate molecular mechanism on binding selectivity of inhibitors X64, X3A, and 4 AU to CDK2 and CDK6. The RMSF analysis and calculations of molecular surface areas indicate that local structural and global flexibility of CDK6 are stronger than that of CDK2. Based on dynamics cross-correlation maps (DCCMs), motion modes of CDK2 and CDK6 produce difference due to associations of X64, X3A, and 4 AU. The calculated binding free energies (BFEs) demonstrate that the compensation between binding enthalpy and entropy of X64, X34, and 4 AU is a key force driving selectivity of inhibitors towards CDK2 over CDK6. This work provides valuable information for designing highly selective inhibitors towards CDK2 and CDK6 and further promotes identification of efficient anticancer drugs in the future.
理解抑制剂对 CDK2 与 CDK6 的选择性分子机制对于改善针对 CDK 家族的药物设计至关重要。采用多种短分子动力学(MD)模拟与 MM-GBSA 方法相结合,研究了抑制剂 X64、X3A 和 4AU 与 CDK2 和 CDK6 结合选择性的分子机制。RMSF 分析和分子表面积计算表明,CDK6 的局部结构和整体灵活性强于 CDK2。基于动力学互相关图谱(DCCMs),由于 X64、X3A 和 4AU 的结合,CDK2 和 CDK6 的运动模式产生了差异。计算得到的结合自由能(BFEs)表明,X64、X34 和 4AU 的结合焓和熵之间的补偿是驱动抑制剂对 CDK2 选择性优于 CDK6 的关键力量。这项工作为设计针对 CDK2 和 CDK6 的高选择性抑制剂提供了有价值的信息,并进一步促进了未来高效抗癌药物的鉴定。